- $42.70m
- $160.64m
- $192.22m
Brief: Biote Announces Pricing Of Secondary Offering Of Common Stock
Brief: Biote Commences Exchange Offer And Consent Solicitation Relating To Warrants
Brief: Biote Corp Reports First Quarter 2023 Financial Results
Brief: Biote Posts Qtrly Revenue Of $44.5 Mln
Brief: Biote Announces Pricing Of Secondary Offering Of Common Stock
Brief: Biote Corp Says Selling Stockholders Are Offering 7.4 Million Shares Of Class A Common Stock - SEC Filing
Brief: Biote Reports Third Quarter Financial Results
U.S. RESEARCH ROUNDUP-Charter Communications, Guild Holdings, Waste Management
IMAC jumps on strategic partnership deal
Brief: Biote Announces Strategic Partnership With IMAC Holdings
U.S. STOCKS ON THE MOVE-Freyr Battery, IQIYI, First Solar
Brief: Biote Announces Approval To Relist On The Nasdaq Stock Market
Brief: Biote Appoints Samar Kamdar As Chief Financial Officer
Brief: Biote Reports Second Quarter 2022 Financial Results
Brief: Biote Corp Received Determination Letter From Panel To Delist Company's Class A Common Stock And Warrants From Nasdaq
Brief: Biote Appoints Ross W. Mcquivey As Chief Medical Officer
NASDAQ RESUMED AT 12:55 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:50 PM
NASDAQ RESUMED AT 12:38 PM